You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 10, October 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Randomized Controlled Trial
 •Hepatobiliary Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effective Control of Hepatic Bleeding With a Novel Collagen-Based Composite Combined With Autologous Plasma—Invited Critique

Harry B. Kram, MD
Torrance, Calif

Arch Surg. 2000;135:1205.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The authors of this article should be congratulated on completing a long-overdue randomized trial evaluating the effectiveness of a combined collagen and fibrin mixture in establishing hemostasis of hepatic bleeding. Previously, other investigators reported the effectiveness of collagen and fibrin glue in controlling hepatic hemorrhage in humans,1 and a controlled experimental comparison of fibrin glue and oxidized cellulose (Surgicel; Johnson & Johnson, New Brunswick, NJ) has been accomplished in an animal model.2 However, a prospective randomized trial comparing fibrin glue mixtures with conventional hemostatic agents in humans has been demanded by scientific purists for some time. Unfortunately, this study falls short of the mark in several respects.

The present prospective trial included patients who underwent hemihepatectomy or segmental resection and were randomly assigned to treatment with either CoStasis Surgical Hemostat (a collagen-based composite combined with autologous plasma) or collagen sponge applied with pressure. Thirty-eight patients received . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effective Control of Hepatic Bleeding With a Novel Collagen-Based Composite Combined With Autologous Plasma: Results of a Randomized Controlled Trial
William C. Chapman, Pierre-Alain Clavien, John Fung, Ajai Khanna, and Andrew Bonham
Arch Surg. 2000;135(10):1200-1204.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Managing Hepatic Bleeding With Autologous Plasma/Collagen-Based Fibrin Sealant
Chapman et al.
Arch Surg 2001;136:967-967.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.